This article first appeared on GuruFocus. Haleon PLC (LSE:HLN) is set to release its Q4 2025 earnings on Feb 25, 2026. The consensus estimate for Q4 2025 revenue is $2.77 billion, and the earnings are ...

As she departs the business, Haleon CMO Tamara Rogers feels that a true appreciation for brand building has been built at the ...

Analysts at Berenberg slightly lowered their target price on consumer health business Haleon from 517p to 510p on Thursday, stating that 2026 should represent "a turning point" in the group's ...

Analysts at Berenberg slightly lowered their target price on consumer health business Haleon from 517p to 510p on Thursday, stating that 2026 should represent "a turning point" in the group's ...

Haleon launched an AI-powered tool this week to promote more inclusive advertising by assessing digital marketing assets for different readability levels and other inclusivity metrics. The consumer ...

Tamara Rogers is departing Haleon having led marketing through its journey to become a standalone company after its spin off from GSK.

Haleon PLC closed 4.55% below its 52-week high of £4.20, which the company achieved on May 30th.

Haleon sells health products internationally with stable operations and modest growth through a good performance in oral health products, and growth in Asia Pacific. The company's financials have ...

Haleon took a kick in the world of sports on Wednesday morning — and scored. The parent company of brands like Advil, Tums, Centrum and Sensodyne announced that it is the official consumer healthcare ...

Advil and Theraflu are products widely recognized by consumers, and though Pfizer did not develop those medicines it owns a stake in those and other over-the-counter healthcare brands thanks to a deal ...

Consumer health care company Haleon may be the first brand to use attention metrics to measure the quality of inventory bought through the Amazon DSP. Haleon, which owns Advil, Tums, Sensodyne and ...